Endometrial Carcinoma

Endometrial carcinoma is a type of cancer that occurs in the lining of the uterus, known as the endometrium. It is one of the most common forms of gynecologic cancer, affecting women primarily after menopause. Risk factors for endometrial carcinoma include obesity, type 2 diabetes, and a lack of physical activity, as well as certain genetic syndromes, such as Lynch syndrome. Symptoms of the disease include abnormal vaginal bleeding, pelvic pain, and vaginal discharge. A diagnosis of endometrial carcinoma is typically made through a combination of imaging tests, such as a transvaginal ultrasound, and tissue biopsies. Treatment options for the disease depend on the stage of the cancer, but may include surgery, radiation therapy, and chemotherapy. Ongoing research in hematology and oncology is focused on developing new ways to detect and treat endometrial carcinoma, including the use of targeted therapies that attack specific genetic mutations in the cancer cells. Additionally, researchers are working to identify biomarkers that can predict which patients may be at higher risk for the disease, as well as which treatments are most likely to be effective for individual patients. Overall, advances in hematology and oncology research are providing new hope for patients with endometrial carcinoma, and are helping to pave the way for better outcomes and improved quality of life for those affected by this challenging disease.